This notion is particularly relevant to lung cancer, where the detection of circulating miRNAs showed that the levels of several miRNAs, such as miR-122 and miR-21, are predictors of EGFR mutation status and efficiency of TKI in patients with NSCLC28–32. Here, EGFR is linked to lung carcinoma.